文献速递咽喉与嗓音

显微喉手术后声带类固醇注射辅助治疗纤维化的患者结局评估

Assessment of Patient Outcomes After Adjuvant Vocal Fold Steroid Injection for Fibrosis After Microlaryngeal Surgery.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2019-01-01

该病例系列纳入228例良性声带病变行显微喉手术的患者,25例(11%)术后出现黏膜波严重减弱或消失的纤维化并接受声带类固醇注射(VFSI)辅助治疗。VFSI后VHI-10和CPP改善,19例(76%)黏膜波恢复正常或轻度减弱,结局与无纤维化患者相当,纤维化率从11%降至3%。

要点

  • 显微喉术后纤维化发生率为11%,VFSI辅助治疗后降至3%。
  • VFSI后76%患者黏膜波恢复正常或轻度减弱。
  • VFSI后VHI-10和CPP改善,与无纤维化患者相当。

核心结论

  • 辅助VFSI与显微喉术后纤维化患者的黏膜波、嗓音质量和发声障碍主观感知改善相关,结局与无纤维化患者相当。
  • 辅助VFSI或可作为挽救技术,将显微喉术后纤维化率从11%降至3%。

研究设计与样本

  • 病例系列,纳入2014年1月至2016年12月在一家三级医疗中心因良性声带病变行显微喉手术的228例连续患者。
  • 25例(11%)术后出现纤维化(VLS示黏膜波严重减弱或消失持续超过术后1个月)并接受辅助VFSI。
  • 数据分析时间为2018年7月1日至2019年4月30日。

主要发现

  • 228例患者中72例男性、156例女性,平均(SD)年龄42.8(12.3)岁。
  • 25例纤维化患者中22例为深部病变采用微瓣技术切除。
  • 17例接受1疗程VFSI,8例接受2次每月连续注射。
  • VHI-10均值:术前24.4分,术后22.1分,VFSI后12.9分;无纤维化203例均值:术前24.8分,术后11.7分。
  • CPP均值:术前4.04,术后4.23,VFSI后5.11;无纤维化患者均值:术前4.33,术后5.15。

关键数值与推荐

  • 纤维化定义为VLS示黏膜波严重减弱或消失持续超过术后1个月。
  • VFSI在门诊局部麻醉下进行,若随访VLS示黏膜波未恢复正常或轻度减弱则每月重复。
  • 25例纤维化患者中19例(76%)VFSI后黏膜波正常(11例)或轻度减弱(8例)。

临床怎么用

  • 对于显微喉术后出现纤维化(黏膜波严重减弱或消失超过1个月)的患者,可考虑辅助VFSI作为挽救治疗。
  • VFSI可在门诊局部麻醉下进行,根据随访VLS黏膜波状态决定是否每月重复注射。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Microlaryngeal surgery (MLS) is one of the most common procedures in laryngology; however, in cases of postoperative fibrosis, few remedial options are available. OBJECTIVE: To investigate the outcomes of vocal fold steroid injection (VFSI) as an adjuvant treatment for fibrosis after MLS. DESIGN, SETTING, AND PARTICIPANTS: Case series of 228 consecutive patients who underwent MLS for benign vocal lesions between January 2014 and December 2016 at a tertiary medical center. Adjuvant VFSI was performed in 25 patients (11%) with postoperative fibrosis, defined as severely decreased or absent mucosal wave on videolaryngostroboscopy (VLS) lasting for longer than 1 month postoperatively. Data were analyzed from July 1, 2018 to April 30, 2019. INTERVENTION: All adjuvant VFSIs were performed in the office under local anesthesia and were repeated monthly if the status of the mucosal wave did not return to normal or mildly decreased on the follow-up VLS. MAIN OUTCOMES AND MEASURES: The outcome parameters, namely, the 10-item Voice Handicap Index (VHI-10), smoothed cepstral peak prominence (CPP) of recorded voice samples, and mucosal wave status on VLS, were measured before and after MLS and after adjuvant VFSI. RESULTS: In this case series of 228 patients (72 men and 156 women; mean [SD] age, 42.8 [12.3] years), 25 had a decreased or absent mucosal wave after MLS, indicating postoperative fibrosis. Of these patients, 22 presented with deep-seated lesions that were removed using a microflap approach. After 1 course of adjuvant VFSI in 17 patients and 2 serial monthly injections in 8 patients, VFSI was associated with improved VHI-10 scores (mean, 24.4 points preoperatively, 22.1 points postoperatively, and 12.9 points after VFSI) that were comparable to the scores of the other 203 patients without vocal fold fibrosis after MLS (mean, 24.8 points preoperatively, 11.7 points postoperatively). Adjuvant VFSI was also associated with improved CPP (mean, 4.04 preoperatively, 4.23 postoperatively, and 5.11 after VFSI) that was comparable to the CPP of the other patients without postoperative fibrosis (mean, 4.33 preoperatively and 5.15 postoperatively). Overall, 19 (76%) of 25 patients with vocal fold fibrosis after MLS had normal (n = 11) or mildly decreased (n = 8) mucosal wave after adjuvant VFSI. CONCLUSIONS AND RELEVANCE: Adjuvant VFSI appeared to be associated with improvements in mucosal wave, voice quality, and subjective perception of dysphonia in patients with fibrosis after MLS, with outcomes comparable to those of the other patients without fibrosis. Adjuvant VFSI may be considered a rescue technique, reducing the rate of fibrosis after MLS from 11% to 3%.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Hsu YC, Liao LJ, Huang TW, et al. Assessment of Patient Outcomes After Adjuvant Vocal Fold Steroid Injection for Fibrosis After Microlaryngeal Surgery. JAMA Otolaryngol Head Neck Surg. 2019. PMID: 31294770. doi:10.1001/jamaoto.2019.1682

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。